San Diego State University is continuing its efforts to support the health and safety of the university community following an announced Meningococcal B outbreak.
Since the outbreak was announced in October 2018, the university, in partnership with the County of San Diego Health and Human Services, has vaccinated thousands of students against the disease. In addition, many other students went to their health-care provider or a local pharmacy to receive the vaccine.
SDSU is asking all students 23 years of age and younger to check their immunization records and to get vaccinated for MenB – a potentially fatal disease spread through close contact with those who are ill.
The effective vaccines for MenB are Trumenba and Bexsero, which were approved by the FDA in 2014-15. Many students did not receive them while in high school but did receive vaccines for other meningitis serogroups.
MenB is life-threatening. Prompt diagnosis and treatment is critical because the disease progresses rapidly and can be fatal in as few as 12 hours after symptoms that often resemble influenza. Click here for FAQs on MenB.